|
BALTIMORE, MD—July 24, 2013—Nurse practitioners, physician assistants, nurses, and other healthcare professionals who treat patients with multiple sclerosis (MS) are currently registering to attend a 2-hour, free educational workshop series, sponsored by Med-IQ, an ACCME-accredited provider of continuing medical education (CME).
Surveying the Landscape of MS Management: The Broad Strokes to the Finer Points is a CME/CE-certified regional workshop series designed to help participants look beyond initial diagnosis and select optimal treatment strategies for their patients with MS. Attendees can expect to learn to identify appropriate patient candidates for disease-modifying therapy, develop an understanding of the clinical benefits and risks of available therapies, evaluate emerging therapies and consider how they might integrate into the current treatment paradigm, and apply strategies to identify and manage suboptimal responders.
The workshops will be held in 10 cities across the United States:
- Alexandria, VA—August 10, The Westin Alexandria
- Atlanta, GA—September 7, The Westin Buckhead
- Denver, CO—August 17, Hyatt Regency Denver Tech Center
- Houston, TX—September 7, The Houstonian Hotel
- Long Island, NY—August 17, Long Island Marriott
- Pittsburgh, PA—September 28, Omni William Penn Place
- San Diego, CA—August 24, Hyatt Regency La Jolla
- San Francisco, CA—September 28, Hyatt Regency San Francisco
- Seattle, WA—September 21, Silver Cloud Hotel—Seattle Broadway
- Tampa, FL—August 24, Renaissance Tampa International Plaza Hotel
Optimal treatment plans for MS are highly variable, as strategies for therapeutic success are often as different as the patients they serve. This variability is due in large part to the many unknowns related to the recent emergence of new agents for the treatment of MS, and their role versus traditional, well established therapies. “The emergence of these newer agents,” said William A. Mencia, MD, CCMEP, Vice President of Education & Medical Affairs at Med-IQ, “combined with a lack of prescriptive practice guidelines, has created an opportunity for positive dialogue between patients and their healthcare providers on the advantages and disadvantages of each type of agent, thus fostering an environment of engagement that can focus the conversation on issues such as proper timing for initiation and monitoring of therapy, slowing progression toward severe disability, and ensuring adherence.”
Each workshop will be from 7:30 to 10:00 AM; breakfast will be served. Interested clinicians can register by calling (toll-free) 866 858 7434, e-mailing info@med-iq.com, or completing this brief online form.
WORKSHOP SERIES CO-CHAIRS
 |
|
Christina Caon, BSN, MSN, NP-C
Assistant Director of Clinical Research
Nurse Practitioner, Multiple Sclerosis Center
Wayne State University School of Medicine
Detroit, MI
|
| |
|
|
 |
|
Kathleen Costello, MS, ANP-BC, MSCN
Assistant Professor/Nurse Practitioner
Johns Hopkins Multiple Sclerosis Center
Baltimore, MD
|
Physicians: Med-IQ is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Med-IQ designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 Physician Assistants: This program has been reviewed and is approved for a maximum of 2.0 hours of AAPA Category I CME credit by the Physician Assistant Review Panel. Physician assistants should claim only those hours actually spent participating in the CME activity. This program was planned in accordance with AAPA's CME Standards for Live Programs and for Commercial Support of Live Programs.
Nurse Practitioners: This program is approved for 2.0 contact hours of continuing education by the American Association of Nurse Practitioners. Program ID 1306253. This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards.
Nurses: Med-IQ is accredited by the California Board of Registered Nursing to provide continuing education to nurses. Provider approved by the California Board of Registered Nursing, provider number CEP 14745, for 2.0 contact hours.
Other: Other healthcare professionals who successfully complete the activity will receive a Statement of Participation indicating the maximum credits available.
This activity is supported by educational grants from Teva Pharmaceuticals and Novartis Pharmaceuticals Corporation.
|
About Med-IQ
Med-IQ, America's most respected provider of continuing medical education (CME), inspires healthcare professionals through award-winning activities that deliver sophisticated outcomes-based educational designs with measurable results in professional competence and performance. Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the California Board of Registered Nursing (CBRN), and the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing medical education to physicians, nurses, and pharmacists, respectively.
Med-IQ, a leader in the development of performance improvement (PI) and quality improvement (QI) CME initiatives, has been recognized by the Alliance for Continuing Education in the Health Professions for our excellence in CE research (William Campbell Felch Award 2013, 2011), educational collaborations (2013), outstanding CME outcomes assessment (2012), and exceptional leadership (Leadership Award 2013, President’s Award 2012). To learn more about Med-IQ, visit www.Med-IQ.com, like us on Facebook, follow us on Twitter, and connect with us on LinkedIn.
For more information, contact: |
close
